Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (341-350 of 760) with videos related to

Pageof 76
Sort By:
The Journal of Invasive Cardiology|April 10, 2008
Short- or long-term outcomes of coronary artery aneurysms occurring after directional coronary atherectomyYuji Oikawa, Junji Yajima, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions|August 17, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot StudySeung-Yul Lee, Young-Hoon Jeong, Kyeong Ho Yun, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 25, 2016
Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trialGrant W Reed, Christopher P Cannon, Jill Waalen, et al.
Journal of Thrombosis and Thrombolysis|January 31, 2015
Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery diseaseMasafumi Ueno, Kosuke Fujita, Hiroyuki Yamamoto, et al.
Expert Opinion on Pharmacotherapy|October 22, 2025
Optimizing selection of P2Y<sub>12</sub> inhibiting therapy: clopidogrel, prasugrel or ticagrelorMattia Galli, Beatrice Simeone, Felice Gragnano, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Effect of an optimized treatment with insulin on platelet reactivity after discharge in patients with an acute coronary syndrome and hyperglycemiaDavid Vivas, Juan C García-Rubira, Esther Bernardo, et al.
JACC. Cardiovascular Interventions|July 8, 2017
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y<sub>12</sub> Receptor-Mediated Signaling in Ticagrelor-Treated PatientsFabiana Rollini, Francesco Franchi, Estela Thano, et al.
The International Journal of Cardiovascular Imaging|September 13, 2007
Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomographyHideki Futamatsu, Chris Klassen, Marco Pilla, et al.
International Journal of Cardiology|September 11, 2010
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromesGiuseppe Biondi-Zoccai, Marzia Lotrionte, Pierfrancesco Agostoni, et al.
JACC. Cardiovascular Interventions|June 25, 2025
Platelet Function Profiles in Patients With Ischemia and Nonobstructed Coronary ArteriesRiccardo Rinaldi, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Pageof 76

Showing results (341-350 of 760) with videos related to

Sort By:
Pageof 76
The Journal of Invasive Cardiology|April 10, 2008
Short- or long-term outcomes of coronary artery aneurysms occurring after directional coronary atherectomyYuji Oikawa, Junji Yajima, Dominick J Angiolillo, et al.
JACC. Cardiovascular Interventions|August 17, 2023
P2Y<sub>12</sub> Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot StudySeung-Yul Lee, Young-Hoon Jeong, Kyeong Ho Yun, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 25, 2016
Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trialGrant W Reed, Christopher P Cannon, Jill Waalen, et al.
Journal of Thrombosis and Thrombolysis|January 31, 2015
Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery diseaseMasafumi Ueno, Kosuke Fujita, Hiroyuki Yamamoto, et al.
Expert Opinion on Pharmacotherapy|October 22, 2025
Optimizing selection of P2Y<sub>12</sub> inhibiting therapy: clopidogrel, prasugrel or ticagrelorMattia Galli, Beatrice Simeone, Felice Gragnano, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Effect of an optimized treatment with insulin on platelet reactivity after discharge in patients with an acute coronary syndrome and hyperglycemiaDavid Vivas, Juan C García-Rubira, Esther Bernardo, et al.
JACC. Cardiovascular Interventions|July 8, 2017
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y<sub>12</sub> Receptor-Mediated Signaling in Ticagrelor-Treated PatientsFabiana Rollini, Francesco Franchi, Estela Thano, et al.
The International Journal of Cardiovascular Imaging|September 13, 2007
Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomographyHideki Futamatsu, Chris Klassen, Marco Pilla, et al.
International Journal of Cardiology|September 11, 2010
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromesGiuseppe Biondi-Zoccai, Marzia Lotrionte, Pierfrancesco Agostoni, et al.
JACC. Cardiovascular Interventions|June 25, 2025
Platelet Function Profiles in Patients With Ischemia and Nonobstructed Coronary ArteriesRiccardo Rinaldi, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Pageof 76